Fig. 5.
Biodistribution of [68Ga]Ga-DATA-TOC and [68Ga]Ga-DOTA-TOC in selected organs and tissues expressed as a percent of injected activity (%IA), b SUV in g/g, and c tumour-to-tissue ratios (SUV/SUV) 60 min after single intravenous injection of [68Ga]Ga-DATA-TOC (control n = 9, blocked n = 8) and [68Ga]Ga-DOTA-TOC (control n = 5, blocked n = 7) in MPC-mCherry tumour-bearing NMRI-nude mice; blocked animals received 100 μg/mouse [Nal3]octreotide acetate together with the radiotracer